Glenmark Pharma (GNP) reported revenues of INR18.8b (+16% YoY; 2% miss), driven by strong growth in the US, Europe, ROW and API businesses. EBITDA margin came in at 17%, in line with our estimate. Reported PAT of INR2.3b (+24% YoY) was 44% above...